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Summary
Background.  —  The  ﬁnger-toe  pathway  could  be  a  good  alternative  for  assessing  arterial  stiffness
conveniently.
Aim. —  To  evaluate  the  accuracy  of  the  pOpmètre® —  a  new  device  that  measures  ﬁnger-toe
pulse wave  velocity  (ft-PWV).
Abbreviations: cf-PWV, Carotid-femoral pulse wave velocity; cf-TT, Carotid-to-femoral transit time; ft-TT, ﬁnger-to-toe transit time;
ft-PWV, Finger-toe pulse wave velocity; ft-TT, Finger-to-toe transit time; PWV, Pulse wave velocity.
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Methods.  —  The  pOpmètre  has  two  photodiode  sensors,  positioned  on  the  ﬁnger  and  the  toe.
Pulse waves  are  recorded  continuously  for  20  seconds,  and  the  difference  in  pulse  wave  transit
time between  toe  and  ﬁnger  (ft-TT)  is  calculated.  The  travelled  distance  is  estimated  using
subject height.  Study  1  compared  ft-PWV  with  carotid-femoral  PWV  (cf-PWV)  obtained  by  the
reference  method  (SphygmoCor®)  in  86  subjects  (mean  age  53  ±  20  years),  including  69  patients
with various  pathologies  and  17  healthy  normotensives.  Study  2  compared  changes  in  ft-PWV
and cf-PWV  during  a  cold  pressor  test  in  10  healthy  subjects.  Study  3  assessed  repeatability  in
45 patients.
Results.  —  ft-PWV  correlated  signiﬁcantly  with  cf-PWV  (R2 =  0.43;  P  <  0.0001).  A  better  correla-
tion was  found  in  terms  of  transit  time  (R2 =  0.61;  P  <  0.0001).  The  discrepancy  between  transit
times was  related  to  age.  The  cold  pressor  test  induced  parallel  changes  in  cf-PWV  and  ft-PWV,
with increased  aortic  stiffness  that  was  reversible  during  recovery.  Intra-session  repeatability
was very  good,  with  a  coefﬁcient  of  variation  of  4.52%.
Conclusion.  —  The  pOpmètre® allows  measurement  of  arterial  stiffness  in  routine  clinical
practice. The  greatest  advantages  of  ft-PWV  are  simplicity,  rapidity,  feasibility,  acceptability
by patients  and  correct  agreement  with  the  reference  technique.  Further  studies  are  needed
to adjust  for  bias  and  to  validate  the  pOpmètre  in  larger  populations.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  La  voie  doigt-orteil  pourrait  représenter  une  bonne  alternative  pour  évaluer  facile-
ment la  rigidité  artérielle.  Le  but  de  cette  étude  était  d’évaluer  l’exactitude  de  pOpmètre
(Axelife  sas  -  France)  un  nouveau  dispositif  de  mesure  de  la  vitesse  de  l’onde  de  pouls  doigt-
orteil (ft-VOP).
Méthodes.  —  pOpmètre® dispose  de  2  capteurs  photodiodes,  placés  sur  le  doigt  et  sur  l’orteil.
La différence  (DOD)  entre  le  pied  de  l’onde  de  l’orteil  et  celle  du  doigt  est  mesurée  pendant
20 s.  La  distance  de  parcours  est  estimée  d’après  la  taille  des  patients.  L’Étude  1  a  comparé  la
ft-VOP à  la  VOP  carotidefémorale  (cf-VOP)  obtenu  par  la  méthode  de  référence  SphygmoCor®
dans  86  sujets  (53  ±  20  ans),  dont  69  patients  atteints  de  diverses  pathologies  et  17  normotendus
sains. L’Étude  2  a  comparé  les  changements  de  ft-VOP  et  cf-VOP  lors  d’un  stress  test  à  froid
dans 10  sujets  sains.  L’Étude  3  a  évalué  la  répétabilité  chez  45  patients.
Résultats.  —  ft-VOP  était  signiﬁcativement  corrélé  avec  cf-VOP  (r2 =  0,43,  p  <  0,0001).  Une
meilleure corrélation  a  été  trouvée  en  termes  de  temps  de  transit  (r2 =  0,61,  p  <  0,0001).  La
différence  entre  les  temps  de  transit  a  été  liée  à  l’âge.  Le  stress  test  a  induit  des  changements
comparables  pour  la  cf-VOP  et  la  ft-VOP:  une  augmentation  de  la  rigidité  aortique  réversible
lors de  la  récupération.  La  répétabilité  intra-session  a  été  très  bonne  avec  un  coefﬁcient  de
variation de  4,52  %.
Conclusion.  —  pOpmètre® permet  de  mesurer  la  rigidité  artérielle  dans  la  pratique  clinique.  Les
plus grands  avantages  de  ft-VOP  sont  la  facilité,  la  rapidité,  la  faisabilité  et  l’acceptabilité  par
les patients,  avec  un  agrément  correct  avec  la  technique  de  référence.  D’autres  études  sont
nécessaires  pour  tenir  compte  des  biais  aﬁn  de  valider  le  pOpmètre  dans  des  populations  plus
importantes.
© 2015  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Aackground
ortic  pulse  wave  velocity  (PWV)  is  the  ‘gold  standard’
f  large  artery  stiffness.  It  is  one  of  the  best  predictors
f  cardiovascular  morbidity  and  mortality,  independent  of
raditional  risk  factors,  in  a  large  number  of  populations
1—4];  this  has  been  established  with  carotid-femoral  PWV
cf-PWV),  a  direct  measurement  of  aortic  stiffness  [5,6].
f
f
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(Although  cf-PWV  is  robust,  reproducible  and  relatively
imple  to  use,  it  may  be  inconvenient  for  routine  use  in  clin-
cs  because  the  measurement  requires  time  and  training.
dditionally,  access  to  the  femoral  artery  might  be  difﬁcult
or  cultural  or  clinical  reasons.  Other  pathways  have  there-
ore  been  investigated,  such  as  brachial-ankle  PWV,  which
rovides  interesting  prognostic  data  [7,8]. The  pOpmètre®
Axelife  SAS,  Saint  Nicolas  de  Redon,  France)  is  an  original
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dFinger-toe  PWV  to  measure  arterial  stiffness  
methodology,  taking  advantage  of  easy  recording  of  the
pulse  wave  at  the  ﬁnger  and  the  toe  using  two  photodiodes
sensors,  and  deriving  ﬁnger-toe  PWV  (ft-PWV).  This  very
simple  technique  may  be  a  good  alternative  for  the  mea-
surement  of  arterial  stiffness  evaluation  in  outpatient  and
epidemiological  settings.  The  pOpmètre  has  already  been
studied  in  the  general  population:  ft-PWV  correlates  with
ageing  [9]  and  is  linked  with  carotid  plaques  in  metabolic
syndrome  [10].  However,  ft-PWV  has  not  yet  been  validated
against  reference  techniques.  Moreover,  the  extent  to  which
ft-PWV  reﬂects  central  or  peripheral  arterial  stiffness  is
unknown.
Accordingly,  the  aims  of  the  present  study  were:  to  com-
pare  ft-PWV  obtained  with  the  pOpmètre  with  the  gold
standard  cf-PWV  (Study  1);  then  to  determine  whether  ft-
PWV  is  altered  similarly  to  cf-PWV  during  acute  sympathetic
stimulation  (Study  2);  and,  ﬁnally,  to  study  the  repeatability
of  the  pOpmètre  PWV  measurement  (Study  3).
Methods
Study 1
A  total  of  86  subjects  were  included:  69  patients  and  17
healthy  normotensives  (42  men;  mean  age  53  ±  20  years;
mean  systolic  blood  pressure  130  ±  18  mmHg)  from  Georges
Pompidou  European  Hospital  and  Broca  Hospital.  Patients
were  either  well-controlled  hypertensive  patients  (n  =  49)  or
patients  with  cognitive  impairment  (n  =  20).  In  each  subject,
ft-PWV  and  cf-PWV  were  measured  in  a  random  order  with
the  pOpmètre  and  the  SphygmoCor® (AtCor  Medical,  Sydney,
Australia).  Measurements  were  performed  according  to  the
recent  expert  consensus  [6].
Additionally,  carotid-radial  PWV  and  femoral-post-tibial
PWV  were  obtained  in  30  subjects  using  the  SphygmoCor.
Blood  pressure  and  heart  rate  were  recorded  by  an  auto-
matic  device  (Colin  BP-880;  Colin  Medical,  TX,  USA)  every
3  minutes  to  calculate  the  mean  blood  pressure  value.
Study 2
The  ‘cold  pressor  test’  was  chosen  as  a  sympathetic  stim-
ulation  [11—13];  it  was  performed  by  immersing  the  right
hand  into  an  ice  water  container  (4—5 ◦C)  for  1  minute.
Ten  healthy  subjects  (4  men;  mean  age  30  ±  8.5  years;
systolic  blood  pressure  118  ±  14.3  mmHg)  were  measured,
and  three  sequences  of  measurements  were  performed:  at
baseline  (every  minute  during  4  minutes),  during  the  test
(at  0,  30  and  60  seconds)  and  during  recovery  (at  30,  60,
90,  120  and  180  seconds).  Blood  pressures  were  recorded
continuously  with  the  oscillometric  device  during  the  test.
We  used  the  Complior® system  (Alam  Medical,  Vincennes,
France)  for  cf-PWV  measurement,  to  obtain  simultaneous
measurement  of  cf-PWV  and  ft-PWV  during  these  dynamic
conditions.Study 3
The  ft-PWV  was  measured  in  45  patients  in  the  nephrology
clinic  of  Tours  Hospital;  38  patients  with  various  patholo-
c
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ies  and  7  healthy  subjects  were  measured  according
o  the  guidelines  [6]  after  10  minutes  of  supine  resting.
easurements  were  done  every  5  minutes.  If  the  two  ﬁrst
easures  differed  by  more  than  0.5  m/s,  then  a  third  was
erformed  and  the  median  retained;  the  two  closest  meas-
res  were  kept  and  the  third  discarded.  All  patients  gave
nformed  consent.
The  study  designs  were  approved  by  the  ethics  committee
f  the  Georges  Pompidou  European  Hospital,  Paris,  France.
ulse wave velocity measurements
he  pOpmètre  was  developed  based  on  similar  assumptions
s  those  for  brachial-ankle  devices  [14—16].  The  pOpmètre
akes  advantage  of  two  photodiode  sensors,  similar  to  pulse
ximeters  [17]  (see  Fig.  1).  The  photodiodes  are  positioned
n  the  ﬁnger  and  the  toe,  so  that  the  pulpar  arteries  are  in
he  scope  of  the  infrared  ray.  The  pOpmètre  measures  the
ransit  time  between  the  foot  of  the  pulse  waves  of  the  ﬁn-
er  and  the  toe,  approximating  the  aortic  pulse  transit  time
f  the  timings  in  the  upper  and  lower  limbs  are  similar;  it
easures  continuously  for  20  seconds  and  simultaneously  on
he  same  pulse  wave.  Two  indices  are  computed:  difference
n  pulse  wave  transit  time  between  toe  and  ﬁnger  (ft-TT;  in
s);  and  ft-PWV  [in  m/s;  ft-PWV  =  k  ×  subject’s  height/ft-
T],  using  a  chart  based  on  the  height  of  187  individuals
easured  in  occupational  medicine  (personal  data),  where  k
s  dependent  on  height.  The  use  of  the  height  chart  relates  to
he  fact  that  the  aortic  valves  correspond  to  an  anatomical
table  landmark  [18].
For  cf-PWV  measurements,  the  SphygmoCor  records
arotid  and  femoral  pulses  successively  and  then,  related  to
he  R  wave  of  the  electrocardiogram,  calculates  the  transit
ime.
The  Complior  measures  the  arterial  pulse  wave  at  the
arotid  and  femoral  sites  simultaneously.  The  travelled  dis-
ance  is  the  direct  distance  between  the  carotid  and  femoral
ites  of  measurement  multiplied  by  0.8,  according  to  the
onsensus  for  the  travelled  distance  measurement  [6].
tatistical analysis
ata  are  expressed  as  means  ±  standard  deviations.  A  value
f  P  <  0.05  was  considered  signiﬁcant.  The  statistical  analysis
as  performed  using  NCSS  2007  (NCSS  LLC,  Kaysville,  UT,
SA).
The  correlation  between  measurement  values  was
nvestigated  using  Pearson  regression  coefﬁcient.  The  Bland-
ltman  plot  [19]  was  used  to  analyse  the  agreement  between
he  two  methods.  The  relative  differences  between  each
air  of  measurements  were  plotted  against  their  mean.
he  discrepancy  between  two  methods  was  studied  using
ultivariable  correlation  analyses  between  the  relative  dif-
erences  and  other  variables.
For  Study  2,  ft-PWV  and  cf-PWV  were  analysed  by  mixed
odels  to  demonstrate  the  evolution  of  blood  pressure,
eart  rate  and  PWV  in  the  same  time  frame.  We  also
etermined  the  correlation  between  changes  in  ft-PWV  and
hanges  in  cf-PWV  during  the  test  and  recovery  period.
In  Study  3,  we  used  the  Bland-Altman  method  for  graphic
epresentation,  and  we  calculated  the  coefﬁcient  of  varia-
ion  as  the  standard  deviation  divided  by  the  mean.
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Figure 1. Pulse wave velocity (travelled distance/time of travel). A = k × height; B = k’ × height. The artery qualities in the upper and
lower limb are similar (muscular arteries) and have quite similar transit times. The distance B—A is approximately equal to the aortic path.
The transit time B—A = t and reﬂects the aortic transit time; this measurement reﬂects the aortic pulse wave velocity. In the top left
c s.
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esults
tudy 1
able  1  shows  the  descriptive  variables  for  the  main  popula-
ion  of  studies  1  and  2,  and  those  of  the  study  3.  As  shown  in
ig.  2,  ft-PWV  correlated  with  cf-PWV  (R2 =  0.43;  P  <  0.0001)
nd  the  plot  of  the  transit  time  of  the  two  methods  showed  a
etter  correlation  (R2 =  0.61;  P  <  0.0001).  Table  2  shows  the
a
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Table  1  Descriptive  variables  for  the  main  population  of  Stud
Variable  Studies  1  and  2
(n  =  86;  42  men)
Age  (years)  53.2  ±  20.0  [22.0—
Height  (cm)  167  ±  11  [147—19
Weight  (kg)  66  ±  16  [52—116
BMI  (kg/m2)  23.1  ±  5.1  [16.8—3
SBP  (mmHg)  130  ±  18  [98—192
MBP  (mmHg)  92  ±  13  [65—139
DBP  (mmHg)  72  ±  12  [52—113
PP  (mmHg) 67  ±  12  [45—121
cf-PWV  (m/s) 8.74  ±  2.15  [5.52—
cf-TT  (ms) 59  ±  14  [32—91]  
ft-PWV  (m/s)  8.52  ±  3.26  [3.58—
ft-TT  (ms)  76  ±  27  [23—150
Normalized  ft-PWV  8.77  ±  2.36  [4.48—
Data are mean ± standard deviation [range]. BMI: body mass index; 
femoral transit time; DBP: diastolic blood pressure; ft-PWV: ﬁnger-toe 
blood pressure; PP: pulse pressure; SBP: systolic blood pressure.ean  values  and  comparisons  of  the  PWVs,  transit  times  and
istances  measured  by  the  two  methods.  Table  3  shows  the
etailed  data  for  controls  and  patients.
In  Fig.  3, the  Bland-Altman  plots  show  individual
elative  differences  (i.e.  [SphygmoCor—pOpmètre]/mean,
xpressed  as  a  percentage)  observed  between  PWVs,
nd  transit  time  values  obtained  by  the  two  methods,
ccording  to  the  mean  level,  calculated  as  (Sphygmo-
or  +  pOpmètre)/2.
ies  1  and  2,  and  for  the  population  of  Study  3.
Study  3
(n  =  45;  28  men)
87.0]  49.7  ±  17.5  [19.1—78.9]
8]  168  ±  8  [151—187]
]  67  ±  12  [40—103]
2.5]  23.5  ±  4.1  [17—34.4]
]  137  ±  8  [96—174]
]  109  ±  68  [43—100]
]  79  ±  11  [51—98]
]  58  ±  16  [26—98]
16.24] —
—
22.53]  11.25  ±  3.94  [5.03—28.20]
]  66  ±  18  [16—127]
14.79]  —
cf-PWV: carotid-femoral pulse wave velocity; cf-TT: carotid-to-
pulse wave velocity; ft-TT: ﬁnger-to-toe transit time; MBP: mean
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Figure 2. Left chart: relationship between carotid-femoral pulse wave velocity (cf-PWV) (m/s) and ﬁnger-toe pulse wave velocity (ft-
PWV) (m/s) (R2 = 0.43; ft-PWV = —0.16 + 0.79 × cf-PWV). Right chart: relationship between the difference in pulse wave transit time at toe
and ﬁnger (ft-TT) (pOpmètre) and carotid-to-femoral transit time (cf-TT) (R2 = 0.61 ﬁnger-to-toe transit time [ft-TT] = —12 + 1.48 × cf-TT).
Table  2  Pulse  wave  velocities,  transit  times  and  differences  between  two  methods.
Mean  ±  SD Difference
SphygmoCor—pOpmètre
Percentage
difference  (%)
R2 P
cf-PWV  (m/s)  8.7  ±  2.2  0.22  ±  2.46  6.1  ±  24.5  0.43  <  0.0001
ft-PWV  (m/s)  8.5  ±  3.3
cf-TT  (ms)  59.4  ±  14.4  —17.5  ±  19.7  —20.3  ±  25.2  0.60  <  0.0001
ft-TT  (ms)  75.9  ±  27.6
SphygmoCor  distance  (cm)  49.4  ±  5.4  —6.8  ±  4.9  —13.3  ±  10.1  0.21  <  0.0001
pOpmètre  distance  (cm)  56.2  ±  3.6
cf-PWV: carotid- femoral pulse wave velocity; cf-TT: carotid-to-femoral transit time; ft-TT: ﬁnger-to-toe transit time; ft-PWV: ﬁnger-toe
pulse wave velocity; SD: standard deviation.
Table  3  Detailed  descriptive  values  for  the  three  populations.
Variable  Healthy  controls
(n  =  17;  29%  women)
Patients  with  cognitive  impairment
(n  =  20;  55%  women)
Hypertensive
patients
Age  (years) 28.6  ±  4.2  74.2  ±  13.1  53.2  ±  15.4
Height  (cm)  171  ±  12  161  ±  10  168  ±  10
Weight  (kg)  64  ±  15  67  ±  12  67  ±  17
BMI  (kg/m2)  21.5  ±  2.6  24.3  ±  6.9  23.2  ±  4.9
SBP  (mmHg)  115.8  ±  9.5  134.4  ±  17.6  132.4  ±  18.4
MBP  (mmHg)  81.1  ±  6.8  95.1  ±  10.5  93.9  ±  14.2
DBP  (mmHg)  64.1  ±  6.7  76.1  ±  9.0  73.1  ±  12.5
HR  (bpm)  66.2  ±  10.0  70.4  ±  14.7  65.9  ±  11.9
cf-PWV  (m/s)  6.73  ±  0.54  10.60  ±  2.35  8.68  ±  1.75
cf-TT  (ms)  73  ±  10  48  ±  11  60  ±  13
ft-TT  (ms)  102  ±  16  55  ±  24  75  ±  24
ft-PWV  (m/s)  7  5.76  ±  0.93  11.04  ±  3.54  8.46  ±  2.86
cf-PWV—ft-PWV  (m/s)  0.98  ±  1.01  —0.44  ±  3.00  0.23  ±  2.53
Difference  in  TT  (ms)  —29.6  ±  14.7  —7.6  ±  6.8  —17.4  ±  20.3
Data are mean ± standard deviation [range]. BMI: body mass index; bpm: beats per minute; cf-PWV: carotid-femoral pulse wave velocity;
cf-TT: carotid-to-femoral transit time; DBP: diastolic blood pressure; ft-PWV: ﬁnger- toe pulse wave velocity; ft-TT: ﬁnger-to-toe transit
time; HR: heart rate; MBP: mean blood pressure; SBP: systolic blood pressure.
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Figure 3. Bland-Altman plot for the analysis of the difference between the two methods. Left chart: comparison of the pulse wave
v rotid-femoral pulse wave velocity; Dtf: difference in pulse wave transit
t standard deviation; TT-cf: carotid-to-femoral transit time.
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Figure 4. Correlation between the relative difference in transit
t
ﬁ
F
ielocities. Right chart: comparison of the transit times. cf-PWV: ca
ime at toe and ﬁnger; ft-PWV: ﬁnger-toe pulse wave velocity; SD: 
Additionally,  the  ft-TT  correlated  with  the  transit  time
etween  the  femoral  artery  and  the  post-tibial  artery  (lower
imbs  artery)  (R2 =  0.16;  P  =  0.03),  but  not  with  the  tran-
it  time  between  the  carotid  artery  and  the  radial  artery
upper  limbs  artery).  The  relative  difference  between  the
ransit  time  obtained  by  the  two  methods  correlated  with
ge  (R2 =  0.41;  P  =  0.0001)  (Fig.  4),  but  not  with  other  clinical
ariables.
tudy 2
he  cold  pressor  test  led  to  signiﬁcant  increases  in  blood
ressure  and  PWV  followed  by  decreases  during  the  recov-
ry  period.  The  changes  in  heart  rate  were  not  signiﬁcant.
oth  cf-PWV  and  ft-PWV  gave  similar  patterns  (Fig.  5).  How-
ver,  the  correlation  between  the  change  in  ft-PWV  and  the
hange  in  cf-PWV  was  weak  (R2 =  0.07;  P  =  0.02).
tudy 3he  repeatability  in  the  intra-session  variability  study  was
ery  good:  three  measurements  were  made  with  the  pOp-
ètre  in  the  same  session,  involving  38  patients  (12  women,
6  men;  mean  age  53.8  ±  15  years)  and  seven  controls  (six
w
f
c
o
igure 5. Left chart: changes in pulse wave velocity (PWV) at baseline
n systolic blood pressure (SBP) at B, CPT and R.ime and age. Dtf: difference in pulse wave transit time at toe and
nger; TT-cf: carotid-to-femoral transit time.omen,  one  man;  mean  age  27  ±  10  years).  In  this  group,
t-PWV  was  11.25  ±  3.94  m/s  (range  5.03—28.2  m/s).  The
oefﬁcient  of  variation  was  4.52%,  with  a  mean  difference
f  0.02  ±  0.50  m/s.
 (B), cold pressor test (CPT) and recovery (R). Right chart: changes
Finger-toe  PWV  to  measure  arterial  stiffness  
0.0
3.0
6.0
9.0
12.0
15.0
18.0
0.0 3.0 6.0 9.0 12.0 15.0 18.0
Carotid to femoral PWV (m/s)
N
or
m
al
iz
ed
 fi
ng
er
-to
e 
P
W
V
 (m
/s
)
Figure 6. Correlation between normalized ﬁnger-toe pulse wave
velocity (ft-PWV) obtained with the pOpmètre and carotid-femoral
PWV (cf-PWV) obtained with the SphygmoCor. Normalization was
done on transit time by matching with the Z-score, and by using the
direct carotid-to-femoral distance. R2 = 0.54; coefﬁcient of varia-
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in  depth,  through  precise  modelling  of  the  arterial  tree,  totion = 0.18; ft-PWV = 1.79 + 0.79 × cf-PWV.
Sensitivity analysis
Because  we  could  see  that  the  discrepancy  between  ft-PWV
and  cf-PWV  was  mainly  caused  by  inadequacy  of  distance
estimation,  we  normalized  ft-PWV  by  using  the  direct  cf-
distance  measured  for  the  SphygmoCor,  and  applied  a
correction  factor  to  the  transit  time,  calculated  by  using  the
Z-score  ([value—mean]/standard  deviation).  By  doing  this,
the  regression  line  of  cf-PWV  and  ft-PWV  came  close  to  the
identity  line,  with  no  residual  bias  and  mean  difference  =  0.
The  correlation  coefﬁcient  R2 was  equal  to  0.54  (see
Fig.  6).
No  side  effects  were  reported  during  the  study,  especially
while  using  the  pOpmètre.
Discussion
In  this  present  study,  we  were  able  to  compare  ft-PWV
measured  by  the  pOpmètre  with  cf-PWV  measured  by
accepted  devices  (SphygmoCor,  Complior).  We  found  that
the  agreement  between  the  pOpmètre  and  the  reference
techniques  was  good,  especially  when  dealing  with  tran-
sit  time,  whereas  when  transit  times  were  translated  into
velocities,  the  agreement  decreased.  Agreement  for  the
transit  time  with  R2 in  the  range  of  0.6  and  coefﬁcients  of
variation  of  20%,  in  the  presence  of  perfect  distance  mea-
surements,  would  lead  to  the  good  category  according  to
the  guidelines  for  validation  of  non-invasive  haemodynamic
measurement  devices  [20].  This  bias  could  be  corrected  by
adequate  calibration  as  a  function  of  age,  but  this  new  cali-
bration  would  need  further  validation  on  a  separate  sample,
ideally  using  magnetic  resonance  imaging,  as  this  technique
can  truly  measure  distance  [6,21].  This  reﬂects  that  the
transit  time  from  ﬁnger  to  toe  is  an  acceptable  proxy  for
e
T
S233
he  carotid-to-femoral  transit  time  (cf-TT),  whereas  the
istance  estimation  initially  proposed  induces  signiﬁcant
ias.  Distance  measurement  is  problematic  even  for  the
arotid-to-femoral  pathway  [6,21,22].  Here,  the  distance
stimation  is  complicated  by  the  fact  that  it  is  impossible  to
se  the  anatomical  landmarks  of  pulse  measurements.  When
istance  was  estimated  via  the  carotid-to-femoral  direct  dis-
ance,  obtained  from  the  SphygmoCor  measurement,  after
dequate  calibration  of  the  distance  measurement  using
xed  coefﬁcients  from  Z-score  analysis,  the  quality  of  the
greement  of  the  transit  time  was  translated  into  the  ft-
WV.  This  new  estimation  of  distance  needs  to  be  validated
n  a  separate  patient  sample.
The  fact  that  age  is  related  to  transit  time  bias  (with
verestimation  of  ft-TT  at  younger  age  compared  with  cf-TT)
ndicates  that  ft-TT  captures  some  additional  information
elated  to  the  ageing  process,  compared  with  cf-PWV.
his  feature  has  been  noted  previously  by  investigators
sing  brachial-ankle  PWV,  which  is  often  more  sensitive
o  metabolic  risk  factors  than  cf-PWV.  Whether  this  par-
icularity  confers  additional  information  or  whether  it  is
etrimental  remains  to  be  studied.
It  was  important  to  show  that  cf-PWV  and  ft-PWV  could
ary  in  the  same  direction  during  acute  changes  in  blood
ressure.  We  have  shown  that  this  is  indeed  the  case,
he  two  techniques  providing  similar  patterns  that  follow
hanges  in  blood  pressure.  It  must  be  noted  that  cf-PWV
s  more  sensitive,  and  its  differences  versus  baseline  were
igniﬁcant  at  0,  30  and  60  seconds  during  the  cold  pressor
est,  whereas  ft-PWV  was  signiﬁcant  only  at  the  end  of  the
old  exposure.  This  could  be  interpreted  in  two  ways.  Either
t-PWV  is  less  robust  than  cf-PWV  or  it  really  is  less  sensi-
ive  to  the  time  of  measurement  of  blood  pressure  effect.
espite  this  lesser  reactivity  to  the  pressor  test,  we  should
ake  into  account  that  the  pOpmètre  is  a  really  easy-to-
se  measurement  device,  totally  investigator  independent,
hereas  measurements  with  the  Complior  are  demanding
nd  require  two  investigators.
The  measurement  repeatability  with  the  pOpmètre  was
ery  good,  especially  as  repeatability  was  obtained  over  a
ide  range  of  PWVs.
The  fact  that  this  measure  is  operator  independent
nd  highly  acceptable  to  patients  helps  to  limit  perturba-
ions  during  the  measurement  session  and  facilitates  good
epeatability.  Further,  the  absence  of  manipulation  of  the
arotid  bifurcations  makes  involuntary  activation  of  the
aroreﬂex  unlikely,  and  the  absence  of  groin  palpation  lim-
ts  patient  stress  and  subsequent  variations  in  blood  pressure
nd  heart  rate.
tudy limitations
his  study  has  several  limitations.  The  number  of  patients
ncluded  complied  with  the  recommendations  [20],  but  was
elatively  small  (n  =  86)  and  may  have  led  to  overoptimistic
esults.  The  physical  principles  also  need  to  be  studied  morexplain  this  level  of  agreement  between  ft-PWV  and  cf-PWV.
he  small  number  of  subjects  also  limits  interpretation  of
tudy  2.
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onclusions
n  conclusion,  the  results  of  this  study  indicate  that  the
t-PWV  is  a  promising  means  of  assessing  arterial  stiffness.
he  greatest  advantages  of  ft-PWV  are  probably  simplicity,
apidity,  feasibility,  patient  acceptability  and  correct  agree-
ent  with  the  reference  technique.  The  good  repeatability
ay  lead  to  its  use  being  considered  in  arterial  stiffness
onitoring  in  long-term  follow-up  of  patients.  This  tech-
ique  is  also  affected  by  age-dependent  bias  in  arterial
tiffness  assessment.  Further  studies  are  needed  to  adjust
he  bias  concerning  peripheral  stiffness  and  age,  and  to  vali-
ate  the  pOpmètre  in  a  larger  population.
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